SILVERARC CAPITAL MANAGEMENT, LLC
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GLUE | 695K | $5.15M |
 | DNTH | 675K | $26.56M |
 | CAMP | 654K | $1.96M |
 | AKRO | 644K | $30.56M |
 | MODD | 640K | $447.54K |
 | CGON | 638K | $25.71M |
 | TRVI | 589K | $5.39M |
 | ABVX | 540K | $45.82M |
 | SNDX | 464K | $7.13M |
 | QURE | 455K | $26.56M |
 | NUVL | 372K | $32.20M |
 | RYTM | 370K | $37.37M |
 | CLDX | 349K | $9.03M |
 | PCVX | 314K | $11.32M |
 | AARD | 307K | $4.08M |
 | BNTC | 276K | $3.88M |
 | VRDN | 260K | $5.60M |
 | BCAX | 251K | $3.96M |
 | VCYT | 236K | $8.09M |
 | SRRK | 234K | $8.71M |
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
695K
Value
$5.15M
Dianthus Therapeutics, Inc.
DNTH
Shares Held
675K
Value
$26.56M
CAMP4 Therapeutics Corporation
CAMP
Shares Held
654K
Value
$1.96M
Akero Therapeutics, Inc.
AKRO
Shares Held
644K
Value
$30.56M
Modular Medical, Inc.
MODD
Shares Held
640K
Value
$447.54K
CG Oncology, Inc. Common stock
CGON
Shares Held
638K
Value
$25.71M
Trevi Therapeutics, Inc.
TRVI
Shares Held
589K
Value
$5.39M
Abivax S.A.
ABVX
Shares Held
540K
Value
$45.82M
Syndax Pharmaceuticals, Inc.
SNDX
Shares Held
464K
Value
$7.13M
uniQure N.V.
QURE
Shares Held
455K
Value
$26.56M
Nuvalent, Inc.
NUVL
Shares Held
372K
Value
$32.20M
Rhythm Pharmaceuticals, Inc.
RYTM
Shares Held
370K
Value
$37.37M
Celldex Therapeutics, Inc.
CLDX
Shares Held
349K
Value
$9.03M
Vaxcyte, Inc.
PCVX
Shares Held
314K
Value
$11.32M
Aardvark Therapeutics, Inc. Common Stock
AARD
Shares Held
307K
Value
$4.08M
Benitec Biopharma Inc.
BNTC
Shares Held
276K
Value
$3.88M
Viridian Therapeutics, Inc.
VRDN
Shares Held
260K
Value
$5.60M
Bicara Therapeutics Inc. Common Stock
BCAX
Shares Held
251K
Value
$3.96M
Veracyte, Inc.
VCYT
Shares Held
236K
Value
$8.09M
Scholar Rock Holding Corporation
SRRK
Shares Held
234K
Value
$8.71M